PHA 6115 LEC - CNS Stimulants

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/90

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

91 Terms

1
New cards

A condition has been hypothesized to be based on the balanced relationship between 5-HT, NE and DA neurotransmitters.

Depression

2
New cards

Example of antidepressant drugs

TCAs (Tricyclic antidepressants)

[SNRIs(Serotonin and Norepinephrine Reuptake Inhibitors),

NSRIs (Norepinephrine/Serotonin Reuptake Inhibitors)],

SSRIs (Selective Serotonin Reuptake Inhibitors),

MAOIs (Monoamine Oxidase Inhibitors),

5HT2 (Serotonin receptor) Antagonist/SRM (Serotonin Reuptake Modulators)

3
New cards

Serotonin deficiency results to

anxiety,

panic,

phobia,

obsessive compulsions

4
New cards

Norepinephrine deficiency results to

decreased concentration,

decreased working memory,

decreased information processing fatigue

5
New cards

Dopamine deficiency results to

cognitive slowing,

hypersomnia,

anhedonia

6
New cards

Deficiency in dopamine and norepinephrine results to

decreased attention,

psychomotor retardation

7
New cards

Deficiency in serotonin and dopamine results to

food craving bulimia

8
New cards

Deficiency in serotonin, norepinephrine and dopamine results to

depressed mood

9
New cards

MOA options of antidepressants:

Agonize 5HT receptors,

Agonize NE receptors,

Block 5HT reuptake,

Block NE reuptake,

Block metabolism by MAO, Or any combination

10
New cards

These agents target a transporter protein: SERT, NET, and DAT

TCAs (SNRIs/NSRIs),

SSRIs (Selective Serotonin Reuptake Inhibitors),

NDRI (Norepinephrine/Dopamine Reuptake Inhibitor), and

SARI (Serotonin-2 Antagonist and Reuptake Inhibitors)

11
New cards

MOA TCAs:

blocks transporter_____ preventing inactivation of NTs, allowing NTs to function

proteins

12
New cards

MOA TCAs:

increased levels of _____, _____, and _____ relieves the signs of NT deficiency — antidepressant activity

5-HT (Serotonin), NE (Norepinephrine), DA (Dopamine)

13
New cards

SNRIs stands for

Selective Norepinephrine Reuptake Inhibitors

14
New cards

NSRIs stands for

Norepinephrine/Serotonin Reuptake Inhibitors

15
New cards

MOA SNRIs:

SNRI - selectively blocks _____

NET (norepinephrine transporter)

16
New cards

MOA NSRI:

NSRI - blocks NET and SERT (binding is dependent on _____ potency ratio)

NE:5HT (norepinephrine:serotonin)

17
New cards

TCAs are known to produce _____ like phenothiazines

"anti-HAM" effect

18
New cards

anti-HAM effect

anti-H1 (sedation),

anti-𝛼1 (orthostatic hypotension),

anti-M1 (dry mouth, constipation, blurred vision, urinary retention)

19
New cards

SAR TCA (SNRI and NSRI):

2° N is essential for _____ selectivity

SNRI

20
New cards

SAR TCA (SNRI and NSRI):

C3-X = _____ activity and affinity for NET & SERT

increases

21
New cards

SAR TCA (SNRI and NSRI):

B-ring side chain must be _____ long ending with an amine, branching side chain decreases affinity for NET & SERT

3 Carbons

22
New cards

SAR TCA (SNRI and NSRI):

Replacement of Ring N with propylene =

max potency

23
New cards

SAR TCA (SNRI and NSRI):

C10-C11 double bond = SAR TCA (SNRI and NSRI):

increase activity

24
New cards

SAR TCA (SNRI and NSRI):

_____-replacement in C10-C11 leads to an E/Z mixture resulting to preferential NET/SERT binding

O

25
New cards

METABOLISM TCA (SNRI and NSRI):

N-demethylation (SNRI = inactivation, NSRI = leads to NET inhibitors),

Aromatic hydroxylation (Atomoxetine, Duloxetine), CYP 2D6 hydroxylation (SNRI at C10; Clomipramine at C8),

CYP 2D6 demethylation (Clomipramine, Venlfaxine, Doxepin),

Glucuronidation

26
New cards

Dibenzazepines TCAs suffix

"-pramine"

27
New cards

Dibenzazepine TCA drug:

SNRI agent (2° amine)

Desipramine

28
New cards

Dibenzazepine TCA drug:

NSRI prototype drug (3° amine)

Imipramine

29
New cards

Dibenzazepine TCA drug:

NSRI agent (3° amine; Cl attachment at A3)

Clomipramine

30
New cards

Dibenzocycloheptadiene TCAs suffix

"-trptyline" (except Doxepin)

31
New cards

Dibenzocycloheptadiene TCA drug:

SNRI Agent; has N5-C12 double bond

Nortriptyline

32
New cards

Dibenzocycloheptadiene TCA drug:

SNRI Agent has C10-11 double bond

Protriptyline

33
New cards

Dibenzocycloheptadiene TCA drug:

NSRI Agent has a propylene moiety in the B-ring

Amitriptyline

34
New cards

Dibenzocycloheptadiene TCA drug:

NSRI Agent (E/Z isomers)

Doxepin

35
New cards

Doxepin E selectively inhibits

NET (Norepinephrine Transporter)

36
New cards

Doxepin Z selectively inhibits

SER (Serotonin)

37
New cards

Non-TCA SNRIs / NSRIs drug:

SNRI Agent; R-enantiomer is more active

Atomoxetine

38
New cards

Non-TCA SNRIs / NSRIs drug:

NSRI agents

Duloxetine,

Milnacipran,

Venlafaxine

39
New cards

SSRIs stands for

Selective Serotonin Reuptake Inhibitors

40
New cards

SAR SSRI:

Electronegative (-X) 4-substitution = essential for _____ and _____ for SERT

selectivity and affinity

41
New cards

SAR SSRI:

SSRI _____ significantly affects SERT selectivity

stereochemistry

42
New cards

MOA SSRI:

inhibits _____with high affinity and selectivity for SERT

SERT (Serotonin Transporter)

43
New cards

METABOLISM SSRI:

highly metabolized in the liver by CYP isozymes (especially CYP 2D6),

N-demethylation for N-methyl SSRIs,

MAO and Glucuronidation (Sertraline)

44
New cards

SSRI drug:

S-isomer is more active

Escitalopram

45
New cards

SSRI drug:

R-isomer; metabolite of Escitalopram

Citalopram

46
New cards

SSRI drug:

E-isomer is essential for SERT inhibition

Fluvoxamine

47
New cards

SSRI drug:

R-isomer more potent; S-isomer higher affinity for SERT

Fluoxetine (aka Happy Pill)

48
New cards

SSRI drug:

(-)-3S,4R-isomer is more active for SERT inhibition

Paroxetine

49
New cards

SSRI drug:

1S,4S-isomer is more active for SERT inhibition

Sertraline

50
New cards

MAOIs stands for

Monoamine Oxidase Inhibitors

51
New cards

MAO is an enzyme responsible for deamination of

amines

52
New cards

5-HT is a substrate for MAO-_____

A

53
New cards

Epinephrine, NE, and DA are substrates for MAO-_____ and MAO-_____

A and B

54
New cards

MAOIs may result in _____ (severe headache, tachycardia, diaphoresis, hyperpyrexia) when combined with sympathomimetics or tyramine-containing food.

hypertensive crisis

55
New cards

SAR MAOI:

some has similar structure with _____

amphetamine

56
New cards

SAR MAOI:

presence of electron-withdrawing groups =

increase potency

57
New cards

MOA MAOI:

inhibits metabolism of NE, 5-HT and DA =

increasing conc. in the brain

58
New cards

METABOLISM MAOI:

Oxidation and N-acetylation

59
New cards

MAOI drug:

reversible inhibitor of MAO-A antidepressant w/o hypertensive crisis

Moclobemide

60
New cards

MAOI drug:

resembles amphetamine with 𝛼-methyl condensing with β-carbon

Tranylcypromine

61
New cards

MAOI drug:

irreversible inhibitor of the enzyme

Phenelzine

62
New cards

MAOI drug:

selective irreversible inhibitor of MAO-B

Selegiline

63
New cards

SARIs stands for

Serotonin-2 Antagonist and Receptor Inhibitor

64
New cards

SRMs stands for

Serotonin Reuptake Modulators

65
New cards

SAR SARI/SRM:

All agents are _____ derivatives

phenylpiperazine

66
New cards

MOA SARI/SRM:

antagonizes _____ receptors and/or selectively inhibits SERT

5-HT2

67
New cards

MOA SARI/SRM (Trazodone):

_____ at 5-HT2A receptor = blocks excitation, hypnotic effects

antagonist

68
New cards

MOA SARI/SRM (Vilazodone):

partial _____ at 5-HT1A receptor postsynaptic releases of 5-HT

agonist

69
New cards

MOA SARI/SRM (Vortioxetine):

_____ at 5-HT1A receptor and SERT inhibitor

agonist

70
New cards

MOA SARI/SRM (Aripiprazole):

_____ at 5-HT2A receptor, and partial agonist at 5-HT1A receptor

antagonist

71
New cards

SARI/SRM drug:

5-HT1A agonist and SERT inhibitor

Vortioxetine

72
New cards

SARI/SRM drug:

with phenylpiperazine ring 5-HT2A antagonist

Trazodone

73
New cards

SARI/SRM drug:

partial 5-HT1A agonist

Vilazodone

74
New cards

NDRI stands for

Norepinephrine/Dopamine Reuptake Inhibitor

75
New cards

_____ is a unique compound acting on monoamine receptors useful in the management of depression and smoking cessation

Bupropion

76
New cards

MOA NDRI:

selective inhibition of DAT (dopmine transporter) and NET (norepinephrine transporter) =

increasing NE (norepinephrine)

77
New cards

T or F: MOA NDRI:

induces release of DA and NE

T

78
New cards

METABOLISM NDRI:

CYP 2B6 alkyl hydroxylation resulting to hemiketal forms and reduction resulting to theo and erythro hydrobupropion isomers and hemiketal

79
New cards

NaSSA stands for

Alpha-2-Noradrenrgic/Selective Serotonin Antidepressants

80
New cards

is single representative of NaSSA that has a complex mechanism of action

Mirtazapine

81
New cards

MOA NaSSA:

blocks presynaptic 𝛂2-adrenergic and 5-HT receptors (may lead to orthostatic hypotension) =

increasing NE and 5-HT levels.

82
New cards

MOA NaSSA:

selectively antagonizes _____ and _____ (may lead to sedation)

5-HT2 and 5HT3

83
New cards

METABOLISM NaSSA:

CYP3A4: N-demethylation and N-oxidation,

CYP 2D6: aromatic hydroxylation

84
New cards

TCA Pharmacophore rings responsible for antidepressants activity

Rings A and C

85
New cards

T or F: TCAs are more prescribed than SSRIs

F

86
New cards

Methylxanthines:

Of caffeine, theophylline, and theobromine, which has moderate effect?

Theobromine

87
New cards

Methylxanthines:

Most potent in CNS Stimulation, Respiratory Stimulation, and Skeletal Muscle Stimulation

Caffeine

88
New cards

Methylxanthines:

Most potent in Diuresis, Coronary Dilation, and Cardiac Stimulation

Theophylline

89
New cards

Methylxanthines:

1,3,7-Trimethylxanthine

Caffeine

90
New cards

Methylxanthines:

1,3-Dimethylxanthine

Theophylline

91
New cards

Methylxanthines:

3,7-Dimethyxanthines

Theobromine